Skip to main content
NIH funding notice PAR-14-184

National Cooperative Drug Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders, Drug or Alcohol Addiction (U01)

Closed on February 23, 2017.

Posted
April 21, 2014
Close date
February 23, 2017
Activity codes
U01
Institutes taking part
NIMH, NIAAA, NIDA

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page names no earlier notice: it is new, or it does not say.

Replaced by PAR-17-185.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,076,696 in first-year total cost, median $1,076,696.

Most frequent study sections

  1. Special Emphasis Panel[ZMH1 ERB-C (04)]1

Most frequent institutions

  1. MOLECULAR NEUROIMAGING, LLC1
Competing awards under PAR-14-184 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2015A Program for Innovative PET Radioligand Development and Application - a translational toolbox for treatments for Mental Health1U01MH107803-01TAMAGNAN, GILLES DMOLECULAR NEUROIMAGING, LLC, CT$1,076,696ZMH1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.